Skip to main content
Premium Trial:

Request an Annual Quote

Caliper to Use SRU's BIND Platform

NEW YORK (GenomeWeb News) – Caliper Life Sciences will use SRU Biosystems' screening platform to offer new functional assays through its Discovery and Alliances services, SRU said today.

Under the agreement, Caliper will use SRU's label-free BIND technology for high-throughput screening and profiling for cell-based and biochemical assays.

The BIND platform can be used to access new hits and lead molecules, including compounds that undergo G-protein switching, non-G coupled pathways, and receptor desensitization, as well as inverse and partial agonists. The technology also can be used for receptor profiling on native cells, SRU said.

Caliper plans to incorporate SRU's platform in contract services it offers to the biotechnology and pharmaceutical research communities.

Financial terms of the agreement were not released.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.